Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

46 results about "Immunofluorescent labeling" patented technology

Immunofluorescent labeling is a straight-forward technique for assessing the presence and subcellular localization of an antigen or a protein. Several labeling methods are available depending on the biological sample, cell preparation, and availability of antibodies against the target.

Gold nanoparticle flower or quantum dot composite probe for living cell immunofluorescent labeling and photothermal treatment

The present invention provides are a gold nanoflower structure and a preparation method therefor. The gold nanoflower structure is a gold nanoflower particle, with round-head columns being uniformly distributed at the periphery thereof, obtained by using gold octahedrons, gold balls or gold tetrahedrons as seed crystals and reducing chloroauric acid by using weak reductant in an environment of high-concentration polyvinylpyrrolidone. In addition, also provided in the present invention are a gold nanoflower/quantum dot composite probe for living cell immunofluorescent labeling and photothermal therapy, a preparation method therefor and a use thereof. In comparison with traditional probes, the probe, incorporates the features of photothermal therapy and fluorescent labeling, and is capable of killing cancer cells in an effective and directional way. Two light sources are adopted to bring a tremendous photothermal conversion efficiency and a greater enhancement on fluorescence intensity of quantum dots respectively, thus mutual interference of two effects are avoided tactfully. The coating of silicon dioxide averts the biotoxicity of the gold nanoflower and the quantum dot effectually, enabling the surface of the composite probe to be easily functionalized and also imparting an extraordinarily excellent biocompatibility to the composite probe.
Owner:THE FIRST AFFILIATED HOSPITAL OF ANHUI MEDICAL UNIV

3D culture, passage, cryopreservation, recovery and identification method for in-vitro organoids based on small intestines of different segments of mice

The invention discloses a 3D culture, passage, cryopreservation, recovery and identification method for in-vitro organoids based on small intestines of different segments of mice. The method comprisesthe following steps: (1) separating recesses of duodenum, jejunum and ileum segments of mice; (2) performing 3D culture on the recesses of the duodenum, jejunum and ileum segments of mice, and forming organoids; (3) performing passage on organoids of small intestines of mice; (4) performing cryopreservation on the organoids of small intestines of mice; (5) performing recovery on the organoids ofsmall intestines of mice; (6) preparing frozen sections of the organoids of small intestines of mice; and (7) performing immunofluorescence labeling and identification on the frozen sections of the organoids of small intestines of mice. Compared with the prior art, the method disclosed by the invention optimizes a recess extraction manner, an in-vitro culture system and a culture medium based on the recesses of the small intestines containing stem cells, and comprises the steps of complete culture, passage, cryopreservation, recovery and identification. The small intestine organoids obtained by the method are capable of performing repeated passage, and the passage organoids have character stability.
Owner:ZHEJIANG GONGSHANG UNIVERSITY

Method for enriching Cryptosporidium parvum oocysts and Giardia Lamblia sporocysts in water

The invention relates to a method for enriching Cryptosporidium parvum oocysts and Giardia Lamblia sporocysts in water. The method comprises the following steps: adding an inorganic metal salt coagulant into a bulk water sample, stirring, coagulating, precipitating, collecting precipitate alumen ustum in a small-volume container, adding acidic solution into the small-volume container to dissolve the alumen ustum, centrifuging, removing supernate and thus, enriching the Cryptosporidium parvum oocysts and Giardia Lamblia sporocysts in water. In the invention, the problems of low Cryptosporidium parvum oocyst and Giardia Lamblia sporocyst enrichment rate, instability, high operation requirement and expensive filtering equipment and consumable items of the conventional method for enriching Cryptosporidium parvum oocysts and Giardia Lamblia sporocysts. The method does not need expensive apparatus and equipment and medicines and greatly reduce capital investment. The method is simple in operation, easy to master, time-saving and labor-saving, reduces cost of enrichment of Cryptosporidium parvum oocysts and Giardia Lamblia sporocysts in water, improves enrichment efficiency and is a novel method which clears the preliminary work for subsequent steps of immunomagnetic separation, immunofluorescence label microscope counting, polymerase chain reaction (PCR) qualitative detection, nano probe gene chip detection and Real-time PCR quantitative detection and the like.
Owner:INST OF URBAN ENVIRONMENT CHINESE ACAD OF SCI

Method for detecting protease-4 of human airway trypsin sample by using flow cytometry

The invention discloses a method for detecting protease-4 of a human airway trypsin sample by using flow cytometry. Specifically, the method comprises the following steps: (1) collecting a marrow or peripheral blood sample; (2) performing immunofluorescent labeling; (3) performing detection with a becton dickinson caliber. According to the detection method disclosed by the invention, a few of marrow cells canbe used as samples, and peripheralblood can be also used as a sample, so that pain of a patient in a sample collecting process can begreatly relieved, and the compliance of the patient is improved. Furthermore, the operation steps in the detection method disclosed by the invention are simple and convenient, and the detection period is short; the detection can be completed within only several hours; the detection period is greatly shortened, the progress of relevant researches can be accelerated favorably, and the time cost is reduced.
Owner:SUZHOU UNIV

Monoclonal antibody of anti-perkinsus membrane protein, preparation method and application thereof

The invention provides a monoclonal antibody of anti-perkinsus membrane protein (MOE). The monoclonal antibody of the anti-perkinsus membrane protein (MOE) is secreted by a hybridoma cell strain IAQ1101 of the anti-perkinsus membrane protein (MOE) with an accession number of CGMCC (China General Microbiological Culture Collection) No.6180. The invention also provides a preparation method and application of the monoclonal antibody. The monoclonal antibody of the anti-perkinsus membrane protein (MOE) is obtained by a genetic engineering technology and an immunological method; by labeling the monoclonal antibody with fluorescence, the immunofluorescence labeling technology is utilized to quickly and accurately detect infected perkinsus in shellfish, accordingly, a reliable immunological detection method is provided for the rapid identification of a port.
Owner:CHINESE ACAD OF INSPECTION & QUARANTINE

Same-section multi-target protein immunohistochemical or immunofluorescent labeling method

The invention provides a same-section multi-target protein immunohistochemical or immunofluorescent labeling method. The method comprises the following steps of: unfolding slices in corresponding liquid in the process of slicing a tissue wax block, selecting two continuously connected slices in the process of catching a target slice, placing the back surface of the first slice upwards in the process of catching the slice by employing a glass slide, and placing the front surface upwards in the process of catching the second slice, so that the condition that the surfaces of the two tissue slice for staining belong to the same slicing surface is ensured; and respectively performing immunohistochemical or immunofluorescent staining on different target proteins for two slices from the same slicing surface, performing overlap comparison on the tissue staining result in a same area, so as to realize existential analysis of a same cell or tissue site multi-target protein. The effect of performing multi-target protein labeling on the same cell or tissue site to be detected is achieved.
Owner:FUZHOU MAIXIN BIOTECH CO LTD

Method for quantitatively detecting 1,3-butadiene-induced cell DNA damage in combination with gas-liquid interface exposure system and high-content technology

The invention discloses a method for quantitatively detecting 1,3-butadiene-induced cell DNA damage in combination with a gas-liquid interface exposure system and a high-content technology. The method comprises the following steps: 1) cell culture; 2) 1,3-butadiene exposure through a gas-liquid interface exposure mode; 3) immunofluorescent labeling of gamma H2AX; 4) high-content detection. The method disclosed by the invention has the advantages that the efficient exposure of gaseous 1,3-butadiene to wall-attached cells in vivo is realized by adopting the in-vitro gas-liquid interface exposure mode, so that the exposure efficiency of the 1,3-butadiene is improved; a high-content imaging system is utilized for automatic imaging, 1,3-butadiene-induced DNA double-chain fracture maker gamma H2AX proteins are quantitatively analyzed, and the direct and quick detection of the cells is realized, so that the sample treatment is more convenient; through high-resolution imaging, not only can the distribution of the gamma H2AX in cell nucleuses be directly observed, but also image data is convenient to store and re-analyze, and the quantitative analysis on the 1,3-butadiene-induced gamma H2AX in each of the cell nucleuses can be realized, so that detection results are more sensitive and accurate.
Owner:CHINA NAT TOBACCO QUALITY SUPERVISION & TEST CENT +1

Immunofluorescence labeling method for proteins in living cells

The present invention discloses an immunofluorescence labeling method for proteins in living cells, and relates to the field of biotechnology. The method comprises following steps: a cell smear is treated through 0.2% TritonX-100 for 10-15 minutes, is washed with 0.01 M PBS for 3-5 minutes, is washed for 3-5 times, is digested with a 0.01 trypsin solution at 37-40 degree Celsius for 12-15 min, iswashed with the 0.01 M PBS for 3 - 5 minutes, is washed for 3 - 5 times, then is blocked with normal rabbit serum, is added with FITC-goat-anti-mouse iGg, is incubated at 37-40 degree Celsius for 30-40 minutes, is washed with the 0.01 M PBS for 3 - 5 minutes, with BrdU used as a protein marker, and after fixed with cross-linking fixative, is observed under a fluorescence microscope. The method canobserve and detect a morphological structure, molecular and ion number of the living cells in real time, can simultaneously study a plurality of target proteins on one specimen, and is suitable for popularization and application.
Owner:陈彩丽

Non-enveloped virus quantum dot marking method and application

The invention discloses a non-enveloped virus quantum dot marking method and application.The method comprises the steps that biotinylation virus suspension is centrifuged, and biotinylation non-enveloped viruses of the uniform structure are obtained; the viruses are inoculated into susceptible cells, quantum dots are added for incubation, and non-enveloped viruses marked with the quantum dots can be obtained.By means of the marked non-enveloped viruses, non-enveloped virus outer capsid protein immunofluorescence marking and cell specific component fluorescent protein positioning, dynamic tracking of a non-enveloped virus living body in the invasion process and positioning of interaction components of the non-enveloped viruses and host cells are achieved.The method can also be used for monitoring the host cell invasion path of the viruses in real time, and is particularly applicable to identifying the interaction components of fish non-enveloped viruses and host cells and also applicable to screening, research and development of fish reovirus resistance preparations.
Owner:INST OF AQUATIC LIFE ACAD SINICA

Application of combination of tissue transparentizing method and histological method to detection of bacteria in tumor

The invention relates to the technical field of detection, and particularly discloses application of combination of a tissue transparentizing method and a histological method in detection of bacteria in tumors. According to the invention, a tissue transparentizing method and a traditional histological method are combined for use, so that the limitation (several microns) on the thickness of a sample can be broken so as to avoid potential pollution on the surface of a thin slice, and a high-resolution and integral three-dimensional image of a large-size tissue sample can be completely constructed so as to achieve three-dimensional visualization of bacteria in tumors; and a tissue with a thickness of 500 microns is selected, optical transparency is achieved through a tissue transparentizing method, and a traditional histological method (such as an immunofluorescence labeling method) is combined for labeling bacteria in the tumor tissue, so that a more accurate experiment result is obtained, and a solid foundation is laid for researching the direct interaction between the microbial population and the tumor cells in the tumor microenvironment.
Owner:ZHUJIANG HOSPITAL SOUTHERN MEDICAL UNIV

Prognostic evaluation method for hepatocellular carcinoma through Telocytes

InactiveCN114034722ASolve the problem of the possibility of prognostic evaluation indicatorsPreparing sample for investigationFluorescence/phosphorescenceParanasal Sinus CarcinomaStaining
The invention relates to the technical field of clinical medicine, in particular to a prognostic evaluation method for hepatocellular carcinoma through Telocytes, which comprises the following steps: taking a postoperative tumor specimen of a hepatocellular carcinoma patient, preparing a frozen section or a paraffin section from a cancer cell para-tissue within a range of 1-2cm from the tumor, carrying out immunofluorescent staining by using CD34 (highly glycosylated I-type transmembrane glycoprotein)/CD117 (III-type transmembrane kinase receptor protein)/PDGFR (platelet-derived growth factor receptor)/vimentin (waveform fibrin) indexes, taking CD34 +/CD117 +/PDGFR +/vimentin-cells as TCs cells, putting para-carcinoma tissues into a general stationary liquid for an electron microscope, performing slicing, and observing the morphology of the TCs cells under a transmission electron microscope. According to the prognostic evaluation method for the hepatocellular carcinoma through the Telocytes, multiple groups of double immunofluorescence markers are adopted, and the cell morphology and the telomere number are observed, so that accurate indexes for prognostic evaluation of patients can be provided for clinicians, and the problem of probability of prognostic evaluation indexes of the patients with the hepatocellular carcinoma is solved.
Owner:许莹
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products